Fact CheckerSign in

NCT07547267Completed

The Effect of Vaginal Dilator Use

The Effect of Vaginal Dilator Use on Female Sexual Function, Self-Compassion, and Quality of Life in Patients After Gynecological Brachytherapy

Source: ClinicalTrials.gov · Last updated 29 Apr 2026

Brief summary (registry, in English)

Objective: This study aimed to investigate the effects of vaginal dilator use on female sexual function, self-compassion level, and quality of life in women undergoing brachytherapy for cervical cancer. Method: The study was conducted using a pre-test post-test quasi-experimental design. The study was conducted with 80 female patients between June 1, 2025, and February 1, 2026. Data were collected using the Patient Identification Form, Self-Compassion Scale-Short Form (SCS-SF), Female Sexual Function Scale (FSFI), and EORTC QLQ-C30. Participants were evaluated at three different time points (week 1, week 4, and week 12).

Status (registry)
Completed
Study type
Interventional
Enrollment
80 (actual)
First submitted
17 Apr 2026
Start date
1 Jun 2025
Primary completion date
1 Feb 2026
Lead sponsor
Istanbul Aydın University
NCT number
NCT07547267

What you commit to

  • Study type: Interventional
  • Participants enrolled: 80
  • From 1 Jun 2025 to the primary completion date, 1 Feb 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Presence of severe psychiatric or cognitive disorders
  • Diagnosis of another active malignancy
  • Severe comorbid conditions that may affect participation

Other

  • Inability to complete questionnaires or follow the study procedures
  • Refusal to participate or withdrawal during the study period

Who the study is looking for

  • Women aged 18 years
  • Diagnosed with cervical cancer
  • Completed external radiotherapy and brachytherapy
  • Initiated vaginal dilator use following treatment
  • Able to communicate and provide informed consent
  • Voluntarily agreed to participate in the study

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Istanbul Aydin University, Besyol Mahallesi, Inonu Caddesi No: 38 Kucukcekmece, Istanbul, Türkiye
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.